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Abstract
Amongst 100 Streptococcus pneumoniae isolated from clinical cases and nasopharynx of
healthy individuals, 60 erythromycin resistant strains were isolated and characterized using
MLST, PFGE, transposon analysis and Quellung reaction. Most of the S. pneumoniae eryth-
romycin resistant (80%) were found to be attributable to the ermB-edncoded ribosome
methylase activity which differs from the dominant mechanism of macrolide resistance seen
in North America.
The most predominant transposons were; Tn1545/6003 (27%), Tn6002 (22%), Tn2009
(20%), Tn2010 (17%). Number of the clinical isolates carrying Tn2010 was more significant
than the normal flora. The serotypes found were; 14 (33%), 3 (22%), 23F (15%), 19F (15%),
19A (7%), 6A (3%), 9V (3%) and 6B (2%). The most prevalent serotypes among the clinical
(n = 28) and normal flora (n = 32) isolates were serotypes 14 (46%) and 3 (31%), respec-
tively. The most prevalent vaccine serotypes amongst the clinical isolates and the healthy
individuals were pneumococcal conjugate vaccines (PCV) 13 and PCV10, respectively.
PFGE revealed 34 pulsotypes with 9 common and 25 single types. Significant number of
the normal isolates belonged to CT5 and CT6. On the other hand, significant number of clini-
cal isolates belonged to CT8 as compared to the normal flora isolates. MLST showed 2
dominant sequence types. ST3130 (23%) and ST180 (22%) were the most predominant
sequence types in the clinical and normal isolates, respectively. There was no significant dif-
ference in other sequence types between clinical and normal flora isolates. Three polyclonal
complexes including Sweden15A -25, Spain23F-1 and Spain9V-3 constituted 58% of the iso-
lates. Our results suggest that the genetic diversity and transposon distribution were high
among S. pneumoniae, particularly in the isolates containing erm(B) and double antibiotic
resistant genes (erm/mef). The results presented here could influence the change in the cur-
rent vaccination practices in Iran which currently calls for vaccination with PCV7 or PCV10.
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Introducation
Streptococcus pneumoniae is a common bacterial pathogen responsible for a numerous com-
munity acquired (CA) infections especially among children and elderly [1]. The pneumococcal
illness varies from self-limiting mucosal infections to life-threatening invasive pneumococcal
diseases [2] and eventual appearance of antibacterial resistance strains.
Macrolides are the most frequently prescribed antibiotic among CA pneumococcal infec-
tions [3]. Macrolide-resistance (MR) in pneumococci is mediated by two major mechanisms
including target site modification by methylases, encoded by ermB (MLSB phenotype) and
efflux pump mechanism mediated by mef (M phenotype) genes with various transposons
[4–6].
A recent trend of the rise of multiple drug resistant (MDR, defined as resistance to at least 3
antimicrobial classes) clinical pneumococcal strains expressing both ermB and mef carried on
Tn2010 [similar to Tn2009 with an additional ermB] has been reported [5]. These isolates are
clonally disseminated and often carry resistance to macrolide, lincosamide and streptogramin
B (MLSB) [7].
The aim of this study was to compare serotyping, antibiotic resistance, clonal diversity and
the presence of genetic elements in the erythromycin resistant S. pneumoniae (ERSP) isolates
obtained from the clinical cases and healthy unvaccinated PCV individuals in Tehran, Iran.
Materials and Methods
Sample collection and identification
A total of 100 clinical and normal flora pneumococcal isolates (50 each) were collected from
hospitals and private clinical laboratories in Tehran, Iran in a two-year study (2011–2013).
The collected patients’ samples were from confirmed cases of meningitis, pneumonia, or bac-
teremia. None of the patients or healthily subjects received any forms of PCV. The normal
flora isolates were collected from healthy nasopharynx individuals who did not have any anti-
biotic treatments for at least 6 months preceding to the sampling and had no serious nasophar-
ynx infections. All procedures were done in accordance with the Declaration of Helsinki
(1975) amended in 2013 [8]. The study was approved by the Ethics Committee of Iran Univer-
sity of Medical Sciences. For privacy reason, the identity of patients and clinical laboratories
form whom/where the isolates had been collected remained anonymous throughout the study.
A written consent, however, was obtained from the control volunteers. Standard microbiolog-
ical techniques were performed for species identification, including hemolysis, Gram staining,
bile solubility and susceptibility to optochin (1μg) disc [9], and identification of isolates was
confirmed by lytA and ply genes using species-specific primers for polymerase chain reaction
(PCR) [10]. Serotyping was performed using the Quellung reaction with antisera (Statens
Serum Institut Copenhagen, Denmark).
Antibiotic susceptibility tests
Disk diffusion method was performed on Mueller-Hinton agar with 5% defibrinated sheep
blood according to the Clinical and Laboratory Standard Institute (CLSI) guideline [9]. Antibi-
otic susceptibility of all erythromycin resistant isolates was determined for oxacillin (1 μg),
tetracycline (15 μg), chloramphenicol (30 μg), vancomycin (30 μg), erythromycin (15 μg) clin-
damycin (2 μg) linezolid (30 ug), quninupristin-dalfopristin (15 ug) and trimethoprim/sulfa-
methoxazole (1.25/23.75 ug). All of the antibiotic discs were purchased from Mast Diagnostics
Ltd (Merseyside, UK). Minimum inhibitory concentrations (MIC) for cefotaxime, ceftriaxone
and amoxicillin was used according to CLSI guidelines. Interpretative criterion for kanamycin
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was based on guideline given by Socie0te0 Franc, aise de Microbiologie (www.sfm.asso.fr) [11].
For erythromycin and clindamycin, the isolates with MIC1μg/ml were classified as resistant.
S. pneumoniae strain. ATCC 49619 was used as the quality control strain [9].
Macrolide resistant phenotype
MR phenotype was determined by the double disk diffusion method with erythromycin and
clindamycin discs (D test) to differentiate constitutive and inducible resistance phenotype [7].
Erythromycin and tetracycline resistance genes PCR amplification of MR genes including
ermB, mefA/E (mef), tetM and transposon related genes were done using previously published
papers [4, 12].
Transposons detection
The presence of transposons was tested using PCR assay for Tn916 and Tn917 genes including
xis, int, tndX, tnpR and tnpA. The resistance genes related to the different transposons were
Tn2009 [tetM, int, xis, mef], Tn6002 (ermB, tetM, int and xis), Tn2010 (ermB, tetM, int, xis,
mefE), Tn3872 (ermB, tetM, tnpA, tnpR), Tn6003/Tn1545 (ermB, tetM, int, xis, aph3’-III) and
Tn1116 (ermB, tetM) [12]. PCR with primer pair J12/J11 which amplified the region orf20 to
orf19 was used to distinguish among Tn3872, Tn6002, and Tn6003/Tn1545, which yield ampli-
cons of 0.8 kb, 3.7 kb, and 7.9 kb, respectively. All primers are listed as S1 Table.
PFGE typing
PFGE typing of the isolates was done as described before [7]. Briefly, genomic DNA was
digested with SmaI enzyme and electrophoresis was done with ramped pulse times beginning
with 5s and ending with 20s at 6 V/cm for 23 h. The banding patterns were read by Dice analy-
sis and clustered by the unweighted pair group method with arithmetic averages (UPGMA)
using Gelcompar II version 4.0 (Applied Maths, Sint-Matenslatem, Belgium).
MLST analysis
Multi locus sequence typing (MLST) was done using seven gene targets including aroE, gdh,
gki, recP, spi, xpt, and ddl [13]. The amplified products were analyzed and the clusters of related
sequence types (ST) were grouped into clonal complexes (CCs) using the eBURST program
(http://eburst.mlst.net/).
Statistical analysis
Differences in the proportions among categorical variables were assessed using Fisher’s exact
test or the χ2 test as appropriate. Where needed statistical analysis was performed between the
patient and normal flora samples.
Results
Bacterial isolates
In all, 60 (60%) ERSP were isolated with 28 (47%) and 32 (53%) isolates belonging to the clini-
cal and normal flora groups, respectively. The number of ERSP isolates (clinical and normal
flora) obtained was significantly higher in the individuals with <15 (76.5%) years old than in
adults)15 years, P<0.05). The rate of ERSP isolates was higher among the invasive (75%)
than non-invasive (43%) clinical isolates.
S. pneumoniae in Iran
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Serotypes distribution
Eight serotypes were identified among the whole isolates. These included serotypes 14 (33%), 3
(22%), 23F (15%), 19F (15%), 19A (7%), 6A (3%), 9V (3%) and 6B (2%) (Table 1). The most
prevalent serotypes among the clinical (n = 28) and normal flora (n = 32) isolates were sero-
types 14 (46%) and 3 (31%), respectively. They were followed by serotypes 19F (25%) and 23F
(14%) for the clinical and serotypes 3 (31%) and 14 (22%) for the normal flora isolates. Addi-
tionally, the serotype 14 was significantly higher (P<0.05) among the invasive (67%) than
non-invasive (23%) clinical isolates. On the other hand, serotype 19F was the most prevalent
serotype in the non-invasive (38%) clinical isolates. Furthermore, the results showed that the
serotypes 19A (13%), 6A (6%) and 6B (3%) were found only in the normal flora which consti-
tuted 22% of the isolates (Table 1).
Antibiotic resistance
All of the ERSP isolates were susceptible to linezolid, vancomycin, imipenem, amoxicillin,
cefotaxime, ceftriaxone, and quinupristin/dalfopristin. The highest resistance was found
against trimethoprim-sulfamethoxazole (93%) followed by tetracycline (85%), clindamycin
(78%), chloramphenicol (48%), penicillin (28%) and kanamycin (25%). In all, 83% of the ERSP
isolates were MDR (resistant to 3 or more classes).
ERSP phenotypes
On the basis of the erythromycin-clindamycin double disk test and MIC, 48 ERSP isolates
were assigned to MLSB phenotype (MIC >256 μg/ml) (80%) and 12 isolates were assigned to
M phenotype (MIC of 1.5 to 16 μg/ml) (20%) (Fig 1). No significant difference in the distribu-
tion of MLSB phenotype amongst the normal (54%) and clinical isolates (46%) was found. On
Table 1. Characteristics of clinical (invasive and non-invasive isolates) and nasopharynx normal flora isolates with respect to their serological,
MLST, PFGE and transposon types.
Serotype
(%a)
Sequence type (%b) Invasive
(%c)
Noninvasive
(%c)
Nor. Flora
(%c)
PFGE (%b) Transposon(%b)
14 (33) 3130 (30), 63 (20),
2678 (15)
10 (77) 3 (20) 7 (22) CT2 (16), SiT (64) 6002 (35), 1545/6003 (25), 2010 (25)
3 (22) 180 (100) 1 (8) 2 (13) 10 (31) CT5 (77), CT6 (23) 3872/3872+Mega (46), 1545/6003
(31), 6002 (23)
23F (15) 81 (67) 1 (8) 3 (20) 5 (16) CT9 (34), CT4 (22), CT7
(22), SiT (22)
2009 (56), 6002 (22)
19F (15) 3130 (89) 2 (15) 5 (33) 2 (6) CT2 (25), CT8 (25), SiT
(25)
1545/6003 (34), 6002 (22), 2010 (22)
19A (7) 166, 199, 271, 5004
(25 each)
0 0 4 (13) CT3 (25), CT6 (25), SiT
(50)
1545/6003 (50), 1116 (25), 2009 (25)
6A (3) 329, 1152 (50 each) 0 0 2 (6) SiT (100) 2009 (50), 2010 (50)
9V (3) 6354, 337 (50 each) 1 (6) 0 1 (3) SiT (100) 2009 (50), 2010 (50)
6B (2) 7577 (100) 0 0 1 (3) SiT (100) 2009 (100)
Abbreviations: CT: Common type, SiT: Single type.
a Percent serotype from the total number of isolates (n = 60),
b percent sequence type corresponding to their respective serotype,
c percent of each category concomitant with the total number of isolates in each group of subjects (invasive n = 13, noninvasive n = 15, normal flora n = 32).
Sequence, PFGE and transposons types with <10% of the isolates were not included.
doi:10.1371/journal.pone.0167803.t001
S. pneumoniae in Iran
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Fig 1. UPGMA dendrogram showing PFGE patterns of clinical (IN = invasive, NON = noninvasive) and normal flora ERSP
isolates. Each pulsotype is shown in relation to the source of isolation, phenotypic and genotypic characteristics of each isolate.
doi:10.1371/journal.pone.0167803.g001
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the other hand, M phenotype was significantly present in the normal (67%) than the clinical
isolates (33%).
Erythromycin resistant genes distribution
No significant difference in the overall rate of erythromycin resistant genes was found between
the clinical and normal flora isolates. The ermB, ermB/mef and mef were carried in 50%, 36%
and 18% of the clinical isolates, respectively. The predominant double resistant genes, ermB/
mef, in the clinical isolates were found in serotype 14 (60%) followed by 19F. Amongst the
ERSP nasopharynx normal flora, 47%, 28% and 25% were ermB, ermB/mef and mef, respec-
tively. In the normal flora isolates, the major serotypes carrying double resistant genes (ermB/
mef) were 19A and 3 (22% each) (Fig 1).
Transposons distribution
Amongst the total 60 ERSP isolates, Tn1545/Tn6003 (27%), Tn6002 (22%) and Tn2009 (20%)
were the most dispersed transposons (Table 2). Tn2010 was the most common transposon in
29% of the clinical isolates followed by Tn1545/6003 (25%). Significant differences between the
clinical and normal flora isolates carrying Tn2009 and Tn2010 were observed. The least com-
mon type of transposons was Tn1116 and Tn3872+MEGA (3% each) in both clinical and nor-
mal flora isolates (Table 2).
No significant correlation was found between the type of transposon and the antibiotic
resistance pattern (Table 3) in the clinical nor normal flora isolates. Resistance to kanamycin
was found only in the isolates carrying Tn1545/Tn6003.
Table 2. Frequency of isolates having different transposons.
Transposon Clinical Normal flora Total
1545/6003 7 (25%) 9 (29%) 16 (27%)
6002 5 (17%) 8 (25%) 13 (22%)
2009 4 (14%) 8 (25%) 12 (20%)
2010 8 (29%) 2 (6%) 10 (17%)
3872 2 (7%) 3 (9%) 5 (8%)
3872+MEGA 1 (4%) 1 (3%) 2 (3%)
1116 1 (4%) 1 (3%) 2 (3%)
Total 28 (47%) 32 (53%) 60
Percentages were calculated from the total number of ERSP isolates (n = 60)
doi:10.1371/journal.pone.0167803.t002
Table 3. Correlation between the types of transposons and their antibiotic resistance patterns in the
ERSP isolates.
Tn Antibiotic Resistant Percent isolates
2009 P, TET, C 12%
2010, 6002, 1116 P, TET, CLD 18%
2010, 6002 P, C, TET, CLD 15%
1545/6003 P, KAN, TET, CLD 15%
3872, 3872+mega C, TET, CLD 12%
All isolates were resistant to SXT. Abberviations; P, penicillin; KAN, kanamycin; CLD, clindamycin; TET,
tetracycline; C, chloramphenicol. Antibiotic resistant patterns with <10% of the total isolates were not
included.
doi:10.1371/journal.pone.0167803.t003
S. pneumoniae in Iran
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PFGE
PFGE analysis of total 60 ERSP isolates showed the presence of 34 pulsotypes with nine com-
mon types (CT) constituting 35 isolates and 25 single isolates (Fig 1). With the exception of
serotype 3, no correlation was found between the serotype and PFGE type in the clinical or
normal flora isolates. All serotype 3 isolates (clinical and nonclinical isolates) were found to be
belonged to a single pulsotype (CT5).
MLST
Using eBURST analysis, we identified 19 different sequence types (ST) with 10 clonal com-
plexes (CCs) (n = 33) and 27 singletons (Figs 1 and S1). Amongst the total 60 ERSP isolates,
the most prevalent STs were ST3130 and ST180 constituting 45% of all isolates followed by
ST81 and ST63 (17%) (Table 4). Ten STs were found with 1 isolate each comprising 16% of the
total isolates. Significant correlations between several serotypes and their STs were found. The
serotypes 3, 19F and 23F showed correlations with ST180 (100%), ST3130 (89%) and ST81
(67%), respectively. On the other hand, serotype 14 isolates showed 9 different STs, the highest
diversity amongst the serotypes. Furthermore, the CC63 (Sweden15A -25) was the most fre-
quent CC constituting 40% of the ERSP isolates (Table 5). Amongst the ten CCs, only CC63
and CC180 were significantly differ between the clinical and normal flora isolates (P>0.05).
The results showed that all of the CC180 were serotype 3 MLSB phenotype (Fig 1) which were
mostly isolated from the normal flora (77%). No new alleles were found in our isolates.
Discussion
In the present study, the overall rate of ERSP was 60% which did not significantly differ
between the clinical and nasopharynx normal flora isolates. The presence of high number of
MDR ERSP isolates (98%) was an indicative of indiscriminate use of antibiotics in general, and
macrolide in particular, in clinical practices with eventual dissemination of the resistant strains
in Iran.
Similar to the results obtained in Asia and some European countries [3, 14–16], we also
found that the most common mechanism (48%) for macrolide resistance in our pneumococcal
isolates was ermB-encoded ribosome methylase activity. On the contrary, efflux mediated
pump gene (mef), which has been reported to be the dominant macrolide resistant in North
American countries [17–18] and Germany [19], was found only in 20% of our isolates. Double
resistant genes were present in 32% of our isolates which was significantly higher than some
Table 4. Distribution of MLST with their respective serotyptes.
Sequence types (%)
Serotype 3130 180 81 63 166 557 2678 878 6354 337 199 271 329 926 1152 2253 3772 5004 7577 Total
14 6 0 0 4 2 2 3 0 1 0 0 0 0 0 0 1 1 0 0 20
19A 0 0 0 0 1 0 0 0 0 0 1 1 0 0 0 0 0 1 0 4
19F 8 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 9
23F 0 0 6 0 0 1 0 1 0 0 0 0 0 1 0 0 0 0 0 9
3 0 13 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13
6A 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 2
6B 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 6
9V 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 2
T% 14(23) 13 (22) 6(10) 4 (7) 3 (5) 3(5) 3(5) 2 (3.3) 2(3.3) 1 (2) 1 (1.6) 1 (1.6) 1 (1.6) 1 (1.6) 1 (1.6) 1 (1.6) 1 (1.6) 1 (1.6) 1 (1.6) 60 (100)
Abbreviations; S: serotype, T: total
doi:10.1371/journal.pone.0167803.t004
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other investigators [20]. The prevalence of dual resistance genes in the pneumococcal isolates
amongst the macrolide resistant isolates has been reported around 16% globally [17, 21] and
up to 63% in China in recent years [22].
Some degree of genetic linkage was observed in this study. Our pneumococcal isolates car-
rying mef were found to be associated with 7 different serotypes (out of 8 serotypes identified),
suggesting mef to be less discriminative than ermB which was found in 5 different pneumococ-
cal serotypes (mostly in serotypes 3 and 14). Furthermore, it was observed that all isolates car-
rying Tn2010 (clinical or normal flora) also harbored double resistant genes (ermB/mef). On
the other hand, no association between the serotypes and transposons or the source of isola-
tion was found. Moreover, we found that many of our isolates could carry wide range of trans-
posons. For examples, serotype 14 in both clinical and normal flora isolates could carry all
major transposons including Tn6002, Tn1545/6003, Tn1116, Tn2009 and Tn2010. In contrary
to the suggestion by Chancey and colleagues [23] that the genetic linkages of Tn2010 with
Tn2009 and Tn6002 may exist, we did not found any coexistence of transposons in our isolates.
Table 2 shows significant difference (p<0.01) in the rate of Tn2010 in the clinical as compared
to normal flora isolates. On the other hand, significant number of the normal flora carried
Tn2009 than the clinical isolates.
Comparative analysis between the report from Asian for Surveillance of Resistant Patho-
gens (ANSORP) on S. pneumoniae isolated from 11 Asian countries [24], which is the most
comprehensive study done so far in the Asia, with the present investigation resulted in several
interesting observations. The frequency of the invasive pneumococcal isolates with 19F sero-
type in our and ANSORP studies was similar (13.3% vs 13.7%). The differences between
ANSORP and our studies were; i) their frequency for serotype 19A was 8.2%, whereas no 19A
serotype was found in our clinical isolates, ii) they found serotype 14 in 7.3% of the cases, we
found in 46% of our clinical isolates (67% for the invasive isolates), iii) serotype 6A (4.2%) was
the most prominent non-PCV7 serotype in the ANSORP report, whilst we observed no 6A
serotype in our clinical isolates, and iv) 52% of ANSORP isolates showed PCV7 serotypes, we
found significantly higher frequency (89%). These observations collectively suggest that several
common S. pneumococcus serotypes have disseminated throughout the Far East, South East
Asia, Middle East countries. On the other hand, some serotypes are highly localized in parts of
Asian countries.
Table 5. Distribution of clonal complex based on the source of isolation.
Clonal complex Clinical Normal flora Total
63 15 (54%)* 8 (28%) 23 (40%)
180 3 (11%) 10 (34%)* 13 (23%)
81 3 (11%) 3 (10%) 6 (11%)
156 3 (11%) 3 (10%) 6 (11%)
230 (ST878), (ST3772) 2 (7%) 1 (33%) 3 (5%)
361 (ST337) 1 (4%) 0 1 (2%)
236 (ST926) 1 (4%) 0 1 (2%)
199 0 1 (3%) 1 (2%)
1876 0 1 (3%) 1 (2%)
271 0 1 (3%) 1 (2%)
28 29 57
* Significantly higher (P<0.05) than the isolates obtained from the other source. Isolates with <10% were not
analyzed.
doi:10.1371/journal.pone.0167803.t005
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Similar to the other reports from Middle East countries [3, 25] the frequencies of our sero-
types included in PCV7 and PCV10 were 89% for clinical, 50% for normal flora and 68% for
total sisolates. Serotype 3 was the only non-PCV7 serotype found in our clinical study. The fre-
quency of the serotypes included in PCV13 was 100% for both clinical and normal flora. For
invasive isolates, the rates of serotypes covered by PCV7or PCV10 and PCV13 were 93% and
100%, respectively. At the present time pneumococcal conjugated vaccine is not routinely used
in Iran and it is only given to a limited number of people who are at high medical risks. Our
results suggested that PVC13 would be the preferred vaccine over PVC7 or PVC10 and can be
implemented in the Iranian national vaccine program.
By using Pneumococcal Molecular Epidemiology Network classification,7 international
resistant clones, including 19 different STs were identified among our clinical isolates. The
most frequent group (23 isolates, 38%) was related to the Sweden15A-25 ST63 international
clone with 57%, 39% and 4% harboring erm(B) alone, mef alone and ermB/mef, respectively.
The second most frequent group was Spain23F-1 ST81 clone (6 isolates, 10%). Additionally,
MLST analysis (at least six common MLST alleles out of 7) revealed nineteen STs with ST3130,
ST180, ST81 and ST63 were the frequent STs covering 62% of the total cases. In a study by
Calatayud and colleagues in Spain [26], 10 ST clones were reported during 1999–2007 period
with Spain23F-1 ST81, Sweden15A-25 ST63 and Spain9V-3 ST156 constituting 30% of their
invasive isolates, we found the 2 international ST clones (Sweden15A-25 ST63, and Spain9V-3
ST156) constituting 73% of our invasive isolates. On the other hand, ST81, ST283 and ST236
have been reported as the most frequent STs in some Asian countries [27, 28]. Overall, our
results suggest that our pneumococcal clonal types were similar to the clones in Europe as
compared to the reports in South Africa, South Korea and United States where high prevalence
of Taiwan19F-14 clonal complex 271 (CC271) has been reported [20].
Conclusions
The present study showed that the rate of resistance of S. pneumoniae strains to erythromycin
was significantly high and the related isolates were clonally disseminated with majority having
MLSB and ermB phenotypic and genotypic characteristics, respectively. Additionally, we
showed that within the ERSP isolates, serotypes 14, 3, 19F and 23F constituted majority (85%)
of the total ERSP isolates which were belonged to ST3130 (CC63), ST180, ST3130 and ST81
clones, respectively. The data presented here suggest that the use of PVC13 could have a signif-
icant protection coverage and should be the recommended vaccine for the Iranian population
living in Tehran.
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